The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Abstract
INTRODUCTION: Combinations of psychotherapy with antidepressants are gold-standard psychiatric treatments. They operate through complex and interactional mechanisms, not unlike the reemergent paradigm of psychedelic-assisted psychotherapy, which promising research suggests may also be highly effective in even challenging populations. AREAS COVERED: We review the therapeutic mechanisms behind both conventional and psychedelic paradigms, including the evolution of this knowledge and the associated explanatory frameworks. We explore how psychedelics have provided insights about psychiatric illnesses and treatments over the past decades. We discuss limitations to early explanatory models while highlighting and comparing the psychological and biological mechanisms underlying many psychiatric treatments. METHODS: , 2020, and iterative retrieval of references from recent reviews and clinical trials. EXPERT OPINION: The contextual model of the common factors of psychotherapy provides a powerful perspective on psychotherapy, antidepressants, and psychedelics, as well as 3,4-methylenedioxymethamphetamine (MDMA) and ketamine. It aligns well with key tenets of psychedelic-assisted psychotherapy. Conventional antidepressants and especially psychedelics may improve the efficacy of psychotherapy via neurochemical changes and increased environmental sensitivity. Combined treatments hold significant promise for advancing the knowledge and treatment of many forms of psychopathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ketamine seems to be mainly offered as a stand-alone pharmacological treatment, like conventional antidepressants (Greenway et al., 2020).”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Greenway et al., 2020
Citations
Cites
1 retracted
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05249-5 · Cited by 359 · cited 1×
“phase 2 trials were sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) from 2004–2016, with results indicating substantial improvements in PTSD symptoms and adequate tolerability to the treatment protocol [224].”
MethodSelf-citationRetractedThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291 · cited 1×
“The global prevalence of psychiatric disorders and their societal impacts are increasing [1,2], and they are now responsible for approximately 28% of illness morbidity worldwide – half of which is attributable to anxiety and depression [2].”
BackgroundFreud, S. (1913) · MacMillan Co eBooks · doi:10.1037/10561-000 · Cited by 5,920
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856 · cited 1×
“rapidly improved depressive symptoms within minutes or hours [173].”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2×
“psychotherapy in 2006 for OCD [208], promising results have been published for applications in end of life anxiety [148,187,209], smoking cessation [210], treatment-resistant depression [211], as well as to initiate meditation/spiritual”
BackgroundCognitive impairment in depression: a systematic review and meta-analysis
Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014) · Psychological Medicine · doi:10.1017/s0033291713002535 · Cited by 2,161 · cited 1×
“This may be due to decreased symptomatology (which frequently includes cognitive changes [75]) increasing therapy efficiency [96], amongst other biological or expectancy effects.”
BackgroundThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work
Wampold, B. E. (2015) · doi:10.4324/9780203582015 · Cited by 1,773
Research works printed but not linked: 22
- Friedrich MJ., 2017, JAMA, 317, 1517
- Bahr R, 2019, P T Peer-Rev. J. Formul. Manag, 44, 340
- Lee MA, 1992, Acid dreams: the complete social history of LSD: the CIA, the sixties, and beyond. Rev. Evergreen ed
- Andrews PW, Front. Psychol
- Kirsch I, Front. Psychiatry
- Hengartner MP. Methodological Flaws, 2017, Front. Psychiatry, 8:275
- Østergaard SD, 2017, Acta Neuropsychiatr
- Sansone RA, 2012, Clin Neurosci, 9, 41
- Davies J, 2019, Behav, 97, 111
- Freud S, 2007, The history of the psychoanalytic movement
- Kirsch I, 2002, Food and Drug Administration. Prev. Treat, 5
- Zilcha-Mano S, 2015, Psychosom, 84, 177
- Kaplan RM, Int J Humanit Soc Sci Educ
- Ban TA, 2007, Neuropsychiatr Dis Treat, 3, 495
- Hurth KP, 2020, Care Med, 1
- Glue P, 20, J Psychopharmacol (Oxf.)
- Kasprow MC, 1999, J Psychother P Res, 8, 12
- Taking Psychedelics BI, 2018, Med, 21, 417
- Winnicott DW, 1953, Int J Psychoanal, 34, 89
- Thiessen MS, 2018, J Psychopharmacol (Oxf.), 026988111877178
- Ross C, 2019, Ann Clin Psychiatry, 31, 271
- Sos P, 2013, Neuro Endocrinol Lett, 34, 287
Cited by
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2096 · Cited by 711
Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162
“Ketamine seems to be mainly offered as a stand-alone pharmacological treatment, like conventional antidepressants (Greenway et al., 2020).”
BackgroundThe molecular pathophysiology of depression and the new therapeutics
Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 102
Metadata
- Authors
- Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A.
- Affiliations
- McGill University (CA)
- Data Services, MAPS Public Benefit Corporation
- Project New Day, Psychedelic.Support
- Corresponding author
- Greenway, Kyle T.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2020-06-01
- Volume
- 13
- Issue
- 6
- Pages
- 655-670
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W3031742716
- Semantic Scholar
- 82347e6b820aa8a3f6105d3ae1955c2a08f52eae
- Cited by
- 94
- References
- 217
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 27 · 2023: 14 · 2022: 13 · 2021: 10 · 2020: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Review of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- psychedelic-assisted psychotherapy, antidepressants, therapeutic mechanisms, MDMA, ketamine, psychedelics, environmental sensitivity, neurochemical changes, psychopathology
- MeSH terms
- Animals, Mental Disorders, Combined Modality Therapy, Hallucinogens, Humans, Psychotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. https://app.cochat.ai/papers/10.1080/17512433.2020.1772054
- The paper
- Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020). Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2020.1772054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.